Vigil Neuroscience, Inc. (VIGL) AI Stock Price Forecast & Investment Analysis
Latest Analysis Date: August 18, 2025
Vigil Neuroscience, Inc. (VIGL) - Comprehensive Stock Analysis & Investment Research
Company Overview & Business Profile
Vigil Neuroscience, Inc. (Stock Symbol: VIGL)
is a leading company in the Life Sciences sector
, specifically operating within the Biological Products, (No Diagnostic Substances) industry.
The organization employs approximately 50 professionals worldwide
.
The company has established itself as
an emerging investment opportunity with substantial growth potential.
Financial Performance & Key Metrics Analysis
Market Capitalization: $384 million - Classified as a
small-cap investment offering high growth potential.
Return on Equity (ROE): -30.3% -
Below-average
shareholder return efficiency, indicating areas for operational improvement.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Vigil Neuroscience, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
Vigil Neuroscience, Inc. strategically competes in the highly dynamic
Biological Products, (No Diagnostic Substances) marketplace,
representing an emerging small-cap investment with substantial growth potential and market disruption capabilities
.
.
Vigil Neuroscience, Inc. Stock Price Chart and Technical Analysis
Loading chart data...
Loading Vigil Neuroscience, Inc. interactive price chart and technical analysis...
Deep dive into Vigil Neuroscience, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.
Understanding Valuation Metrics
What these metrics mean: Valuation metrics help determine if Vigil Neuroscience, Inc. stock is fairly priced compared to its earnings, assets, and market position.
How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.
For Vigil Neuroscience, Inc.: With a P/E ratio of -1.06, the market sees the stock as potentially undervalued.
P/E Ratio-1.06x
P/B Ratio9.30x
Market Cap$384M
EPS$-2.10
Book Value/Share$0.87
Understanding Profitability Metrics
What these metrics mean: These ratios measure how efficiently Vigil Neuroscience, Inc. converts revenue into profit and generates returns for shareholders.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For Vigil Neuroscience, Inc.: An ROE of -30.3% indicates room for improvement in shareholder value creation.
ROE-30.3%
ROA-29.2%
ROIC-30.2%
Understanding Financial Health Metrics
What these metrics mean: These ratios assess Vigil Neuroscience, Inc.'s ability to meet short-term obligations and manage debt levels effectively.
How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.
For Vigil Neuroscience, Inc.: A current ratio of 25.83 indicates strong liquidity.
Current Ratio25.83x
Quick Ratio24.75x
Financial Leverage1.04x
Understanding Cash Flow Metrics
What these metrics mean: Cash flow metrics reveal Vigil Neuroscience, Inc.'s ability to generate cash from operations and fund growth initiatives.
How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.
For Vigil Neuroscience, Inc.: Free cash flow of $-53M indicates cash challenges that need attention.
Operating Cash Flow$-53M
Free Cash Flow$-53M
Understanding Operational Efficiency Metrics
What these metrics mean: These ratios measure how effectively Vigil Neuroscience, Inc. uses its assets and manages working capital.
How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.
For Vigil Neuroscience, Inc.:
Understanding Financial Statement Data
What these metrics mean: Key figures from Vigil Neuroscience, Inc.'s income statement and balance sheet showing absolute financial performance.
How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.
For Vigil Neuroscience, Inc.:
Income Statement ($ Millions)
Operating Income$-61M
Net Income$-61M
R&D Expense$41M
Balance Sheet Highlights ($ Millions)
Total Current Assets$99M
Cash & Short-term Investments$95M
Total Liabilities$4M
Dividend & Shareholder Information
Shares Outstanding48M
Growth Metrics (YoY)
EPS Growth-74.6%
Vigil Neuroscience, Inc. (VIGL) Fundamental Analysis & Insider Trading Data
(Quarterly Financial Reports)
Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Vigil Neuroscience, Inc. stock analysis.
Loading fundamental data...
Loading Vigil Neuroscience, Inc. comprehensive fundamental analysis and insider trading data...
Latest Vigil Neuroscience, Inc. Stock News & Market Analysis
Breaking news, analyst reports, and market updates affecting Vigil Neuroscience, Inc. (VIGL) stock price and investment outlook.
We recently published an article titled Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025. In this article, we are going to take a look at where Vigil Neuroscience, Inc. (NASDAQ:VIGL ...
Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’ s disease to the neurology pipeline. Paris, May 22, 2025. Sanofi announced today that it has ...
Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain ...
WATERTOWN, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment ...
Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update Mar. 26, 2024 7:05 AM ET Vigil Neuroscience, Inc. (VIGL) ...
We can see that insiders own shares in Vigil Neuroscience, Inc.. It has a market capitalization of just US$153m, and insiders have US$1.6m worth of shares, in their own names.
--Vigil Neuroscience, Inc., a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that the U.S ...
WATERTOWN, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment ...
Stay ahead of market moves. Get critical insights with Premium » Vigil Neuroscience to Present at Stifel 2024 Virtual CNS Days Mar. 12, 2024 7:05 AM ET Vigil Neuroscience, Inc. (VIGL) ...
Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain ...
Net Loss: Net loss from operations for the first quarter ended March 31, 2025 were $22.4 million, compared to $19.9 million for the same period in 2024. About Vigil Neuroscience ...
Vigil Neuroscience, Inc. Competitors & Peer Analysis - Life Sciences Sector
Comparative analysis of Vigil Neuroscience, Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.
Frequently Asked Questions - Vigil Neuroscience, Inc. Stock Forecast
How accurate are Vigil Neuroscience, Inc. stock predictions?
Our AI model demonstrates 62% historical accuracy for VIGL predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
What factors influence Vigil Neuroscience, Inc. stock price forecasts?
Is Vigil Neuroscience, Inc. a good investment in 2025?
Based on our AI analysis, Vigil Neuroscience, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.
How often are Vigil Neuroscience, Inc. forecasts updated?
Vigil Neuroscience, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.
Want More Advanced Vigil Neuroscience, Inc. Analysis?
Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Vigil Neuroscience, Inc. stock.
